Prime Medicine to Present at Jefferies Global Healthcare Conference

Core Insights - Prime Medicine, Inc. is a biotechnology company focused on developing one-time curative genetic therapies using its proprietary Prime Editing platform [3][4] - The CEO, Allan Reine, will participate in a fireside chat at the Jefferies Global Healthcare Conference on November 18, 2025 [1] - A live audio webcast of the event will be available on the company's website, with a replay accessible for 90 days post-event [2] Company Overview - Prime Medicine is dedicated to creating advanced gene editing therapies, aiming to repair various genetic mutations across multiple tissues and organs [3] - The company is advancing a diversified portfolio of therapeutic programs primarily in liver, lung, immunology, and oncology [4] - Prime Medicine plans to expand its therapeutic potential beyond current diseases to include genetic, immunological, and infectious diseases, impacting millions of people [4]